Wegovy, every mention

mentionsepisodesper episode tap a year for its mentions

Verbatim, from the transcripts: the passages where Wegovy comes up

loading…

▶ 27:27 Jordi Hays A few months ago, someone told me they had heard a rumor that a banker hedge fund had banned its traders from taking Ozempic, Wegovia, and other GLP-I weight loss drugs.

▶ 1:16:43 John Coogan Anyway, uh, the Waguvi maker, that's Novo Nordisk, has cut ties with the telehealth company, HIMSS and HERS, citing allegations of deceptive marketing practices and drug compounding. 7 times in the scene
▶ 1:37:31 Jordi Hays Theoretically, Wagovi gives them a million doses, and then HIMSS is somehow selling 1.2 million doses of Wagovi. 2 times in the scene

▶ 0:40 John Coogan The ad positioned Hims and Hers, which sells a compounded version of semaglutide, a copy of the active ingredient in Novo Nordisk's Weguvi and Ozempic, as a Robin Hood of healthcare.
▶ 6:25 John Coogan We'd be like, let's make as much as possible in every possible lab, and so the, the, the fundamental rule makes sense, and so the FDA recently declared the shortage of Eli Lilly's Monjaro and Zep bound over, but Novo's, uh, Ozempic and…
▶ 12:12 Jordi Hays Generally are going to do better than you could be ordering, you know, compounded would go V and it's just some dude in, in a random compounding pharmacy that could just be one room somewhere.

▶ 4:03 John Coogan Uh, approved semaglutide as a weight loss product under the brand name Waguvi.
▶ 42:48 John Coogan And so, um, there's something interesting going on with Waguvi specifically. 8 times in the scene
▶ 56:30 John Coogan It notes that WGUVI, semaglutide for obesity, costs more per prescription than Ozempic. 3 times in the scene

Turn any episode into a week of clips.